Cover Image
市場調查報告書

中國的Tacrolimus市場分析

Investigation Report on China Tacrolimus Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 296866
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的Tacrolimus市場分析 Investigation Report on China Tacrolimus Market, 2010-2019
出版日期: 2015年06月11日 內容資訊: 英文 30 Pages
簡介

Tacrolimus(別名:FK506,FR-900506),由藤澤藥品工業(與山之內製藥的合併,現在是Astellas Pharma Inc.)開發。1993年6月作為「Prograf」在日本第一次獲得許可。Tacrolimus是免疫抑制劑,主要用於同類器官移植後,抑制患者的免疫系統運作,降低內臟器官排斥反應的風險。1994年獲得FDA許可,現在在複數國家與地區市場銷售。1998年,Tacrolimus製劑(注射和膠囊)已批准進口中國。

本報告提供中國的Tacrolimus市場相關調查分析、主要廠商的市場佔有率、醫院市場上的銷售價格、主要製造商簡介、醫院市場上的市場佔有率(各劑型)、市場預測等。

第1章 Tacrolimus的相關概念

  • 適應
  • 全球市場銷售情形

第2章 中國的Tacrolimus的市場概要

  • 專利及核准狀況
  • 主要製造商
  • 市場規模

第3章 中國的Tacrolimus的銷售額分析

  • 總銷售額
  • 銷售額:各地區

第4章 中國的Tacrolimus的銷售量分析

  • 整體銷售量
  • 銷售量:各地區

第5章 中國的Tacrolimus的主要廠商的市場佔有率分析

  • 市場佔有率:各銷售額
  • 市場佔有率:各銷售量

第6章 中國的Tacrolimus(各劑型)的市場規模分析

  • 各市場佔有率:銷售額、劑型
  • 各市場佔有率:銷售量、劑型

第7章 中國的醫院市場上的Tacrolimus標準價格

  • Astellas Pharma Manufacturing,Inc.(US)
  • 千壽製藥
  • Sichuan Med-Shine Pharmaceutical Co., Ltd
  • Sinopharm Chuankang Pharmaceutical Co., Ltd
  • 山之內製藥
  • Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
  • Zhejiang Hisun Pharmaceutical Co.,Ltd.
  • 藤澤藥品工業

第8章 中國的Tacrolimus的主要製造商

  • Astellas Pharma Inc.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
  • Sichuan Med-Shine Pharmaceutical Co., Ltd
  • 山之內製藥

第9章 中國的Tacrolimus市場預測

  • 市場規模的預測
  • 競爭格局的預測

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 1506204

Tacrolimus (also FK506) is a macrolide lactone immunosuppressive drug discovered from a soil sample that contained the bacterium Streptomyces tsukubaensis in 1984 by Fujisawa Pharmaceutical Co., Ltd. Tacrolimus acts like cyclosporine and its systemic use is mainly for the prevention of allograft rejection and the treatment of immune disease. Different from cyclosporine, it can penetrate through epidermis barrier due to its relatively small molecular mass. Therefore to avoid systemic adverse reactions, it can be made into external preparation to treat various immune inflammatory cutaneous disorders.

After entering China in 1999, tacrolimus develops fast with annual sales rising from less than CNY 100 million in 2005 to CNY 688 million in 2014 and CAGR reaching up to 24.7% during this period. Tacrolimus in the Chinese market are in four formulations: injection, capsule, eye drop and ointment, among which the sales value of capsules takes up over 90% of the sum in 2014. Tacrolimus is used for a variety of indications, for example, capsules are mainly used to prevent graft rejection after liver or kidney transplantation.

Tacrolimus in the Chinese market mainly comes from the following companies: Fujisawa Pharmaceutical Co., Ltd (Ireland), Hisun, Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, Sichuan Med-Shine Pharmaceutical Co., Ltd and Astellas Pharma Manufacturing,Inc, among which Fujisawa Pharmaceutical Co., Ltd (Ireland) has the largest market share of 75.40% by sales value in 2014.

As the number of organ transplants and the number of the cases of immune disease increase, the sales value of tacrolimus in China is expected to keep growing.

Readers can get at least the following information from this report:

  • market share of manufacturers of tacrolimus in China
  • price of tacrolimus in Chinese market
  • major manufacturers of tacrolimus in Chinese market
  • share of dosage forms of tacrolimus in China
  • market outlook of tacrolimus in China

The author suggests the following groups of people purchase this report:

  • manufacturers of immunosuppressants
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Tacrolimus

  • 1.1. Indication
  • 1.2. Developments in Global Market

2. Market Profile of Tacrolimus in China

  • 2.1. Patent and Approval Status of Tacrolimus in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Value of Tacrolimus in China, 2010-2014

  • 3.1. Overall Sales Value
  • 3.2. Sales Value by Regions

4. Survey on Sales Volume of Tacrolimus in China, 2010-2014

  • 4.1. Overall Sales Volume
  • 4.2. Sales Volume by Regions

5. Survey on Market Share of Major Manufacturers of Tacrolimus in China, 2010-2014

  • 5.1. Market Share by Sales Value
  • 5.2. Market Share by Sales Volume

6. Survey on Market Size of Dosage Forms of Tacrolimus in China, 2010-2014

  • 6.1. Market Share of Different Dosage Forms by Sales Value
  • 6.2. Market Share of Different Dosage Forms by Sales Volume

7. Reference Retail Price of Tacrolimus in China in 2014

  • 7.1. Astellas Pharma Manufacturing,Inc.(US) (Trade Name: Prograf)
  • 7.2. Senju Pharmaceutical Co., Ltd (Japan) (Trade Name: Protopic)
  • 7.3. Sichuan Med-Shine Pharmaceutical Co., Ltd (Trade Name: Ming Zhi Xin)
  • 7.4. Sinopharm Chuankang Pharmaceutical Co., Ltd (Trade Name: Yi Li Kang)
  • 7.5. Yamanouchi Pharmaceutical Co., Ltd (Japan)
  • 7.6. Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
  • 7.7. Zhejiang Hisun Pharmaceutical Co.,Ltd.
  • 7.8. Fujisawa Pharmaceutical Co., Ltd (Ireland) (Trade Name: Prograf)

8. Major Manufacturers of Tacrolimus in the Chinese Market, 2010-2014

  • 8.1. Astellas Pharma Manufacturing,Inc.
  • 8.2. Zhejiang Hisun Pharmaceutical Co.,Ltd.
  • 8.3. Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
  • 8.4. Sichuan Med-Shine Pharmaceutical Co., Ltd
  • 8.5. Yamanouchi Pharmaceutical Co., Ltd (Japan)

9. Market Outlook of Tacrolimus in China, 2014-2018

  • 9.1. Forecast of Market Size
  • 9.2. Forecast of Competitive Landscape

Selected Charts

  • Chart Patent Status of Tacrolimus in China
  • Chart Approval Information of Tacrolimus in China
  • Chart Sales Status of Tacrolimus in China, 2010-2014
  • Chart Sales Value of Tacrolimus in China, 2010-2014
  • Chart Sales Value of Tacrolimus in Some Regions in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Tacrolimus for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Tacrolimus Made by Fujisawa (Ireland) in China, 2010-2014
  • Chart Sales Value and Market Share of Tacrolimus Made by Hangzhou Zhongmei Huadong in China, 2010-2014
  • Chart Sales Value and Market Share of Tacrolimus Made by Yamanouchi (Japan) in China, 2010-2014
  • Chart Sales Value and Market Share of Tacrolimus Made by Hisun in China, 2010-2014
  • Chart Sales Value and Market Share of Tacrolimus Injections in China, 2010-2014
  • Chart Sales Value and Market Share of Tacrolimus Eye Drops in China, 2010-2014
  • Chart Sales Value and Market Share of Tacrolimus Capsules in China, 2010-2014
  • Chart Price of Tacrolimus Made by Astellas Pharma Manufacturing,Inc.(US) in Some Regions in China
  • Chart Price of Tacrolimus Made by Senju Pharmaceutical Co., Ltd (Japan) in Some Regions in China
  • Chart Price of Tacrolimus Made by Yamanouchi Pharmaceutical Co., Ltd (Japan) in Some Regions in China
  • Chart Price of Tacrolimus Made by Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd in Some Regions in China
  • Chart Price of Tacrolimus Made by Hisun in Some Regions in China
  • Chart Price of Tacrolimus Made by Fujisawa Pharmaceutical Co., Ltd (Ireland) in Some Regions in China
Back to Top